- Home
- TORO vs LUCD Comparison
TORO vs LUCD Comparison
Compare TORO & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TORO | LUCD |
|---|---|---|
| Founded | 2022 | 2018 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 192.9M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TORO | LUCD |
|---|---|---|
| Price | $4.41 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 39.6K | ★ 1.5M |
| Earning Date | 10-20-2026 | 11-11-2026 |
| Dividend Yield | ★ 48.36% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | N/A | $33.93 |
| Revenue Next Year | N/A | $165.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $3.30 | $0.50 |
| 52 Week High | $8.50 | $1.63 |
Technical Indicators
Market Signals| Indicator | TORO | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 31.96 | 33.10 |
| Support Level | $3.50 | $0.50 |
| Resistance Level | $5.30 | $1.09 |
| Average True Range (ATR) | 0.50 | 0.07 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 18.56 | 35.14 |
Price Performance
Historical ComparisonAbout TORO Toro Corp.
Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.